TrialFrontiers in immunology2025

Impact of treatment interruption on the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis: a

Qunyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.